SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-16-089276
Filing Date
2016-03-21
Accepted
2016-03-21 17:26:25
Documents
1
Group Members
GRANT GRASMICKLOUIS GRASMICKNANCY GRASMICK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v434897_sc13da.htm SC 13D/A 93889
  Complete submission text file 0001144204-16-089276.txt   95654
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Subject) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81959 | Film No.: 161519437
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 8840 WILSHIRE BLVD. 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 6715 QUAD AVENUE BALTIMORE MD 21237 310-358-3200
Nancelou, Inc. (Filed by) CIK: 0001593134 (see all company filings)

IRS No.: 510591172
Type: SC 13D/A